Medical/Pharmaceuticals
RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn's
U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035 Opaganib's 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opaganib also undergoing two oncology Phase 2 U.S. studies a...
2021-08-23 19:00
3739
Everest Medicines to Announce Half-Year 2021 Interim Results
SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...
2021-08-23 15:20
2957
NeuExcell Therapeutics names Russ Addis as Vice President, Research
STATE COLLEGE, Penn., Aug. 23, 2021 /PRNewswire/ -- NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Russ Addis, Ph.D. to the new position of Vice President, Research, effective immediately. Dr. Addis will report directly to Dr. Ronald HW Lorijn, Chief Executive ...
2021-08-23 13:00
1524
Menarini Enters into an Exclusive Licensing Agreement with Daiichi Sankyo to Commercialise TARLIGE(R) in Singapore, Malaysia, and the Philippines
SINGAPORE, Aug. 23, 2021 /PRNewswire/ -- A. Menarini Asia-Pacific Holdings Pte. Ltd., part of the leading Italian global biopharmaceutical company Menarini Group, signed a multi-year exclusive licensing agreement to assume the registration, sales, marketing, and distribution of the orally adminis...
2021-08-23 09:00
1820
Inclusion of Kintor as a Constituent Stock of HSCI
SUZHOU, China, Aug. 23, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company's stock has been included in the Hang Seng Composite ...
2021-08-23 08:44
2554
Ocumension Therapeutics Announces 2021 Interim Results
Company loss narrowed sharply by 96% Business Income Increased By More Than 26 Times Year-on-Year Core Product OT-401 Approval Imminent HONG KONG, Aug. 21, 2021 /PRNewswire/ -- The Chinese ophthalmology platform company,Ocumension Therapeutics ("Ocumension" or the "Company", together with its s...
2021-08-21 00:19
16423
Insilico Medicine Collaborates with BioNova to Develop Small Molecule Drugs for Hematologic Malignancies
SHANGHAI, Aug. 20, 2021 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence-driven drug discovery company, and BioNova Pharmaceuticals (Shanghai) Ltd. ("BioNova"), a clinical-stage biopharmaceutical company, today announced entry into a collaboration agreement to...
2021-08-20 21:12
4230
Argon Medical Devices, Inc. Announces the Commercial Launch of the SKATER™ Mini-Loop Drainage Catheter
FRISCO, Texas, Aug. 20, 2021 /PRNewswire/ -- Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the commercial launch of SKATER™ Mini-Loop Drainage Catheters inthe United States and the European Union. The SKATER™ Mini-Loop is a drain...
2021-08-20 21:00
3246
CStone Pharmaceuticals Selected as a Constituent of HSCI
SUZHOU, China, Aug. 20, 2021 /PRNewswire/ -- CStone Pharmaceuticals (HKEX: 2616, "CStone" or the "Company"), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, announced that the Company has bee...
2021-08-20 20:24
5273
Bupa Global launches Private Client, a first in market service redefining premium healthcare with dedicated Lifecare Concierge
Research reveals a rising interest in personalised and preventative healthcare amongst high net-worth individuals * Insights show there is continued impact from the pandemic, with 80% of HK top executives/ HNWIs having experienced mental health symptoms over the past year, with the most common...
2021-08-20 16:18
2166
Standigm Expands Global Footprints with New Office in Cambridge, UK
SEOUL, South Korea, Aug. 20, 2021 /PRNewswire/ -- Standigm, a leading workflow AI drug discovery company, today announced the opening of a new office in Cambridge, United Kingdom ("UK"), to accommodate the company's rapid growth in the European market. Founded in 2015, Standigm has proprietary ...
2021-08-20 15:30
1229
RapidAI Achieves Record Momentum Amid Demand for Improved Clinical Decision Making and Patient Workflow
SAN MATEO, Calif., Aug. 19, 2021 /PRNewswire/ -- RapidAI, the global leader in neurovascular and vascular imaging driving the next evolution of clinical decision making and patient workflow, today announced record corporate momentum with more than2.8M scans to date on its platform — the most clin...
2021-08-19 22:00
1642
Shielding Our Singapore Spirit: Mamoru Marketing Shields More Than 12,000 NDP 2021 Participants with Clinical Grade ECOM products
SINGAPORE, Aug. 19, 2021 /PRNewswire/ -- Celebrating Singapore's 56th year of independence, Mamoru Marketing Pte Ltd, exclusive distributor for ECOM products inSingapore, is proud to partner with the National Day Parade (NDP) 2021 for the first time this year to lend a hand in ensuring a COVID-Sa...
2021-08-19 20:47
2929
Zhaoke Ophthalmology's Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint
Largest Ever Completed Dry Eye Disease (DED) clinical trial to date in China Zhaoke Ophthalmology's in-house developed innovative drug candidate Targeting NDA Filing by the End of 2021 Dry Eye Disease Affects Over 200 Million People in China Potential to become new standard of care for moderate-to-s...
2021-08-19 12:43
3042
MedAlliance Announces Enrollment of First Patient in Erectile Dysfunction Feasibility Study with Sirolimus Drug-Eluting Balloon
NYON, Switzerland, Aug. 19, 2021 /PRNewswire/ -- MedAlliance has announced enrollment of the first patient in an erectile dysfunction (ED) feasibility study with its sirolimus drug-eluting balloon [DEB]. This occurred at the University of Rome Tor Vergata,Italy, under the direction of the study's...
2021-08-19 08:00
1922
MicroConstants to Join BioAgilytix Family
Highly complementary transaction strengthens BioAgilytix's ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientists DURHAM, N.C., Aug. 19, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), ...
2021-08-19 02:30
1570
BioCheck Inc Acquires DRG International Inc, a leading IVD company
Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA andChemiluminescent immunoassay platforms SOUTH SAN FRANCISCO, Calif., Aug. 19, 2021 /PRNewswire/ -- BioCheck, Inc. has announced that it has acquired DRG International, a leading manufac...
2021-08-19 00:04
2115
Sai Life Sciences opens new Discovery Biology facility at its integrated R&D campus in Hyderabad, India
HYDERABAD, India, Aug. 18, 2021 /PRNewswire/ -- Sai Life Sciences, a leading
globalContract Research, Development & Manufacturing Organization
2021-08-18 20:20
2473
HistoIndex's Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints in Sagimet's NASH FASCINATE-2 Phase 2b Clinical Trial
SINGAPORE, Aug. 18, 2021 /PRNewswire/ -- HistoIndex
2021-08-18 18:00
1418
Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY
- Revenue of KRW 303.7 billion ($269.1 million) is record for second quarter, up 11 percent year-over-year - 1H'21 Revenue at KRW 655.5 billion ($580.8 million), 58 percent achievement based on total sales in FY2020 - Favorable market conditions expected in second half amid an increasing dem...
2021-08-18 18:00
1461
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
9065
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
8421
Where does China's production capacity come from?
2024-05-10 12:01
8252
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4997